| Oxidative phosphorylation is a metabolic vulnerability in chemotherapy-resistant triple-negative breast cancer KW Evans, E Yuca, SS Scott, M Zhao, N Paez Arango, CX Cruz Pico, ... Cancer research 81 (21), 5572-5581, 2021 | 84 | 2021 |
| Combining neratinib with CDK4/6, mTOR, and MEK inhibitors in models of HER2-positive cancer M Zhao, S Scott, KW Evans, E Yuca, T Saridogan, X Zheng, H Wang, ... Clinical Cancer Research 27 (6), 1681-1694, 2021 | 38 | 2021 |
| Incidence of nausea and vomiting after intragastric balloon placement in bariatric patients–a systematic review and meta-analysis J Trang, SS Lee, A Miller, CXC Pico, A Postoev, I Ibikunle, CA Ibikunle International Journal of Surgery 57, 22-29, 2018 | 38 | 2018 |
| Noninvasive mechanical ventilation in patients with chronic obstructive pulmonary disease and severe hypercapnic neurological deterioration in the emergency room KHB Claudett, MHB Claudett, MACS Wong, MG Andrade, CX Cruz, ... European Journal of Emergency Medicine 15 (3), 127-133, 2008 | 31 | 2008 |
| Genomic, transcriptomic, and proteomic profiling of metastatic breast cancer A Akcakanat, X Zheng, CX Cruz Pico, TB Kim, K Chen, A Korkut, A Sahin, ... Clinical Cancer Research 27 (11), 3243-3252, 2021 | 21 | 2021 |
| Does single-port laparoscopic sleeve gastrectomy result in improved short-term perioperative outcomes compared to conventional multi-port laparoscopic sleeve gastrectomy? C Lo, L Latin, Á Fariñas, CXC Pico, A Postoev, C Ibikunle, A Sanni International Journal of Surgery 22, 67-71, 2015 | 13 | 2015 |
| Poland syndrome with extracorporeal intercostal liver herniation and thoracic myelomeningocele FG Seifarth, CXC Pico, J Stromberg, VM Recinos, VF Burdjalov, ... Journal of Pediatric Surgery 47 (1), e13-e17, 2012 | 12 | 2012 |
| Natural language processing–assisted literature retrieval and analysis for combination therapy in cancer J Zeng, CX Cruz Pico, T Saridogan, MA Shufean, M Kahle, D Yang, ... JCO Clinical Cancer Informatics 6, e2100109, 2022 | 8 | 2022 |
| University of Texas MD Anderson Cancer Center FX Claret United States, 0 | 6 | |
| Augmented Reality and Its Role in Abdominal Laparoscopic Surgical J Hua, K Holton, A Miller, I Ibikunle, CC Pico | 2 | 2019 |
| Are the postoperative outcomes of malabsorptive bariatric procedures truly superior to restrictive bariatric procedures? L Latin, C Lo, A Sanni, C Ibikunle, A Farinas, CC Pico, A Postoev Surgery for Obesity and Related Diseases 11 (6), S164-S165, 2015 | 2 | 2015 |
| Postoperative Outcomes of Surgical Sutureless Aortic Valve Replacement vs Transcatheter Aortic Valve Implantation for Severe Symptomatic Aortic Stenosis J Chung, A Postoev, A Filatov, L Ladoris, A Farinas, CXC Pico, A Postoev, ... Journal of the American College of Surgeons 221 (4), S26, 2015 | 2 | 2015 |
| Updates in the Pathology and Therapy of BRCA Germline–Associated Breast Cancer with a Focus on HER2 Amplification DW Kim, CX Cruz Pico, E Forester, A Belsare, K Whitaker, E Obeid, ... Current Breast Cancer Reports 15 (4), 364-370, 2023 | | 2023 |
| The role of micro-CT for intraoperative margin assessment of breast cancer. M Vasigh, SM Meshkati Yazd, AS Papazoglou, A Liatsos, K Ranjbar, ... Journal of Clinical Oncology 41 (16_suppl), e13620-e13620, 2023 | | 2023 |
| Disparities in the recommendation, acceptance, and performance of surgery as treatment modality for patients with stage 0-III breast cancer. CX Cruz Pico, ML Pierotti, JS Hasler, AD Williams, EA Handorf, AA Aggon, ... Journal of Clinical Oncology 41 (16_suppl), e18509-e18509, 2023 | | 2023 |
| 10-year mastectomy trends among breast cancer phenotypes: A national cohort study. ML Pierotti, CX Cruz Pico, JS Hasler, AD Williams, EA Handorf, AA Aggon, ... Journal of Clinical Oncology 41 (16_suppl), 584-584, 2023 | | 2023 |
| Antitumor activity of the ATR inhibitor Elimusertib in patient-derived xenograft models with DNA damage response pathway alterations K Varadarajan, CX Pico, K Evans, MG Raso, Y Rizvi, X Zheng, TP Diperi, ... Cancer Research 83 (7_Supplement), 6180-6180, 2023 | | 2023 |
| Anti-tumor activity of ATR inhibitor BAY 1895344 in patient-derived xenograft (PDX) models with DNA damage response (DDR) pathway alterations CXC Pico, D Li, CD Lanier, K Evans, MG Raso, T DiPeri, Y Rizvi, MJ Ha, ... MOLECULAR CANCER THERAPEUTICS 20 (12), 2021 | | 2021 |
| Abstract P058: Anti-tumor activity of ATR inhibitor BAY 1895344 in patient-derived xenograft (PDX) models with DNA damage response (DDR) pathway alterations CXC Pico, D Li, CD Lanier, K Evans, MG Raso, T DiPeri, Y Rizvi, MJ Ha, ... Molecular Cancer Therapeutics 20 (12_Supplement), P058-P058, 2021 | | 2021 |
| Abstract 676A: Overcoming PARP inhibitor resistance with molecularly guided rational combinations in triple-negative breast cancer patient-derived xenograft models CXC Pico, KW Evans, K Chen, X Zheng, A Akcakanat, M Zhao, C Tapia, ... Cancer Research 80 (16_Supplement), 676A-676A, 2020 | | 2020 |
CA IbikunleProfessor of Surgery, Georgia Regents UniversityVerified email at georgiasurgicare.com
